Company intelligence / Profile preview
Tivic Health Systems, Inc.
- Ownership
- Public · TIVC
- Employees
- ~7
- Development stage
- Commercial
Overview
ClearUP® Sinus Pain Relief is FDA-cleared and CE-marked as a handheld bioelectronic device to treat sinus pain/congestion. Clinical studies show efficacy in reducing symptoms of allergies/sinusitis. The company’s non-invasive cervical vagus nerve stimulation device has shown rapid effects on autonomic nervous system measures in early clinical studies. The lead biologic candidate Entolimod™ has completed late-stage development for acute radiation syndrome with prior government funding support.
- Therapeutic areas
- ImmunologyHematology
- Modalities
- DeviceBiologic
- Industry
- Biotech
Drug pipeline
13 assets12 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Tivic Health Systems, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tivic Health Systems, Inc..